Page last updated: 2024-11-05

2,4-thiazolidinedione and Brain Neoplasms

2,4-thiazolidinedione has been researched along with Brain Neoplasms in 1 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research Excerpts

ExcerptRelevanceReference
"Glioblastomas represent 15% of brain tumors."2.58Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma. ( Chellappan, DK; Dahiya, R; de Jesus Andreoli Pinto, T; Dua, K; Gupta, G; Mishra, A; Sharma, S; Singhvi, G, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, G1
Singhvi, G1
Chellappan, DK1
Sharma, S1
Mishra, A1
Dahiya, R1
de Jesus Andreoli Pinto, T1
Dua, K1

Reviews

1 review available for 2,4-thiazolidinedione and Brain Neoplasms

ArticleYear
Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma.
    Panminerva medica, 2018, Volume: 60, Issue:3

    Topics: Animals; Brain Neoplasms; Glioblastoma; Glucose; Humans; Insulin; Ligands; Lipids; Mice; PPAR gamma;

2018